Host: |
Rabbit |
Applications: |
IHC/IF/ELISA |
Reactivity: |
Human/Rat/Mouse |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit polyclonal antibody anti-A-kinase anchor protein 12 (301-350 aa) is suitable for use in Immunohistochemistry, Immunofluorescence and ELISA research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide. |
Purification: |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
Concentration: |
1 mg/mL |
Dilution Range: |
IHC 1:100-1:300IF 1:200-1:1000ELISA 1:20000 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
AKAP12 |
Gene ID: |
9590 |
Uniprot ID: |
AKA12_HUMAN |
Immunogen Region: |
301-350 aa |
Specificity: |
AKAP 250 Polyclonal Antibody detects endogenous levels of AKAP 250 protein. |
Immunogen: |
The antiserum was produced against synthesized peptide derived from the human AKAP12 at the amino acid range 301-350 |
Function | Anchoring protein that mediates the subcellular compartmentation of protein kinase A (PKA) and protein kinase C (PKC). |
Protein Name | A-Kinase Anchor Protein 12Akap-12A-Kinase Anchor Protein 250 KdaAkap 250GravinMyasthenia Gravis Autoantigen |
Database Links | Reactome: R-HSA-9013405Reactome: R-HSA-9035034 |
Cellular Localisation | CytoplasmCell CortexCytoskeletonMembraneLipid-AnchorMay Be Part Of The Cortical Cytoskeleton |
Alternative Antibody Names | Anti-A-Kinase Anchor Protein 12 antibodyAnti-Akap-12 antibodyAnti-A-Kinase Anchor Protein 250 Kda antibodyAnti-Akap 250 antibodyAnti-Gravin antibodyAnti-Myasthenia Gravis Autoantigen antibodyAnti-AKAP12 antibodyAnti-AKAP250 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance